Pharmacist intervention when interacting drugs are prescribed despite alerts [1]

American Journal of Health-System Pharmacy

Volumn 62, Issue 17, 2005, Pages

  Chan, Agnes L F ^a  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMIODARONE; CISAPRIDE; DIGOXIN; DOPAMINE RECEPTOR; FUROSEMIDE; KETOROLAC; METOPROLOL; MINOCYCLINE; PENICILLIN G; PHENYTOIN; POTASSIUM CHLORIDE; PROPRANOLOL; VERAPAMIL; WARFARIN;

ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CLINICAL PHARMACY; COMBINATION CHEMOTHERAPY; COMPUTER ANALYSIS; DECISION MAKING; DRUG CROSS REACTIVITY; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HUMAN; LETTER; PRESCRIPTION; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 24144432239     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050131     Document Type: Letter

References (2)

1. Murphy JE, Forrey RA, Desiraju U. Community pharmacists' responses to drug-drug interaction alerts. Am J Health-Syst Pharm. 2004; 61:1484-6.
2. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. JAMA. 1997; 277:301-6.